Updating results

Multiple sclerosis in adults: management (CG186)

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment.

Clinical guideline Published October 2014 Last updated November 2019

Cannabis-based medicinal products

Everything NICE has said on cannabis-based medicinal products in an interactive flowchart.

NICE Pathway Published November 2019

Multiple sclerosis

Everything NICE has said on multiple sclerosis in an interactive flowchart

NICE Pathway Published October 2014 Last updated November 2019

Cannabis-based medicinal products (NG144)

This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.

NICE guideline Published November 2019

Skin conditions

Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart

NICE Pathway Published March 2015 Last updated November 2019

Fever in under 5s: assessment and initial management (NG143)

This guideline covers the assessment and early management of fever with no obvious cause in children aged under 5. It aims to improve clinical assessment and help healthcare professionals diagnose serious illness among young children who present with fever in primary and secondary care.

NICE guideline Published November 2019

Urinary tract infections

Everything NICE has said on diagnosing, treating and managing urinary tract infections including lower (cystitis), upper (acute pyelonephritis) and recurrent UTIs in people with or without a catheter in an interactive flowchart

NICE Pathway Published August 2012 Last updated November 2019

Postnatal care

Everything NICE has said on the essential care that every woman and her baby should receive in the first 6–8 weeks after birth in an interactive flowchart

NICE Pathway Published May 2011 Last updated November 2019

Bacterial meningitis and meningococcal septicaemia in under 16s

Everything NICE has said on managing bacterial meningitis and meningococcal septicaemia in children and young people in an interactive flowchart

NICE Pathway Published July 2012 Last updated November 2019

Maternal and child nutrition

Everything NICE has said on maternal and child nutrition in an interactive flowchart

NICE Pathway Published November 2012 Last updated November 2019

Social and emotional wellbeing for children and young people

Everything NICE has said on supporting the social and emotional wellbeing of children and young people in an interactive flowchart

NICE Pathway Published December 2011 Last updated November 2019

Antenatal and postnatal mental health

Everything NICE has said on antenatal and postnatal mental health in an interactive flowchart

NICE Pathway Published November 2011 Last updated November 2019

Fever in under 5s

Everything NICE has said on assessing and initiating management of fever with no obvious cause in children under 5 in an interactive flowchart

NICE Pathway Published May 2013 Last updated November 2019

Commissioning for Quality in Rheumatoid Arthritis (CQRA)

Shared learning Published January 2012

Bronchiolitis in children

Everything NICE has said on diagnosing and managing bronchiolitis in children in an interactive flowchart

NICE Pathway Published June 2015 Last updated November 2019

Respiratory conditions

Everything NICE has said on respiratory conditions in an interactive flowchart

NICE Pathway Published June 2015 Last updated October 2019

Generalised anxiety disorder

Everything NICE has said on managing generalised anxiety disorder in adults in primary, secondary and community care in an interactive flowchart

NICE Pathway Published March 2012 Last updated October 2019

Pressure ulcers

Everything NICE has said on preventing and managing pressure ulcers in all age groups in primary care and community settings in an interactive flowchart

NICE Pathway Published January 2012 Last updated October 2019

Abortion care

Everything NICE has said on abortion care in an interactive flowchart.

NICE Pathway Published September 2019 Last updated October 2019

Ibrutinib with rituximab for treating Waldenstrom's macroglobulinaemia (terminated appraisal) (TA608)

NICE is unable to make a recommendation about the use in the NHS of ibrutinib (Imbruvica) with rituximab for treating Waldenstrom’s macroglobulinaemia in adults

Technology appraisal guidance Published October 2019

Ramucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal) (TA609)

NICE is unable to make a recommendation about the use in the NHS of ramucirumab (Cyramza) for treating unresectable hepatocellular carcinoma after sorafenib

Technology appraisal guidance Published October 2019

Non-Hodgkin's lymphoma

Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart

NICE Pathway Published July 2016 Last updated October 2019

Liver cancers

Everything NICE has said on liver and bile duct cancers in an interactive flowchart

NICE Pathway Published November 2013 Last updated October 2019

Multi-disciplinary pathway development for individual with dementia and a learning disability

A multi-disciplinary working group was set up to look at how the NICE guidance for dementia should be applied to adults with a learning disability.

Shared learning Published October 2008

Enhancing the Quality of Heart Failure Care

Shared learning Published January 2017

What is the clinical and cost effectiveness, post treatment and at longer-term follow‑up, of behavioural activation compared with other psychological therapies in children aged 5 to 11 years and young people aged 12 to 18 years with mild or moderate to severe depression?

Recommendation ID NG134/5 Question What is the clinical and cost effectiveness, post treatment and at longer-term follow‑up, of behavioural

Research recommendation Published October 2019

What is the clinical utility of bone turnover markers in the diagnosis and management of primary hyperparathyroidism?

Recommendation ID NG132/1 Question What is the clinical utility of bone turnover markers in the diagnosis and management of primary...

Research recommendation Published October 2019

What is the prognostic value of different risk stratification methods for people with locally advanced prostate cancer?

Recommendation ID NG131/7 Question What is the prognostic value of different risk stratification methods for people with locally advanced

Research recommendation Published October 2019

What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate cancer?

Recommendation ID NG131/3 Question What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate

Research recommendation Published October 2019

How effective are education-based alcohol prevention interventions (universal or targeted) for children and young people aged 11 to 25 with SEND in full-time education?

Recommendation ID NG135/5 Question How effective are education-based alcohol prevention interventions (universal or targeted) for children

Research recommendation Published October 2019

What is the most clinically and cost-effective pathway for excluding the clinically significant progression of cancer in people with low- to intermediate-risk prostate cancer?

Recommendation ID NG131/4 Question What is the most clinically and cost-effective pathway for excluding the clinically significant progression

Research recommendation Published October 2019

At what gestation should treatment with prophylactic vaginal progesterone for the prevention of preterm birth be started and stopped?

Recommendation ID NG25/7 Question At what gestation should treatment with prophylactic vaginal progesterone for the prevention of preterm

Research recommendation Published October 2019

Does progesterone reduce the risk of preterm birth in women who have a short cervix (cervical length of 25 mm or less), but do not have other risk factors for preterm birth?

Recommendation ID NG25/6 Question Does progesterone reduce the risk of preterm birth in women who have a short cervix (cervical length of

Research recommendation Published October 2019

Does progesterone reduce the risk of preterm birth in women who have risk factors for preterm birth, but do not have a short cervix (cervical length of more than 25 mm)?

Recommendation ID NG25/5 Question Does progesterone reduce the risk of preterm birth in women who have risk factors for preterm birth, but

Research recommendation Published October 2019

What is the best and most cost-effective management strategy for people whose first surgery for primary hyperparathyroidism is not successful?

Recommendation ID NG132/2 Question What is the best and most cost-effective management strategy for people whose first surgery for primary

Research recommendation Published October 2019